Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases

被引：22

作者：

Andreev-Drakhlin, Alexander ^{[1
]}

Cabanillas, Maria ^{[1
]}

Amini, Behrang ^{[1
]}

Subbiah, Vivek ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JCO PRECISION ONCOLOGY | 2020年 / 4卷

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1200/PO.20.00096

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1302 / 1306

页数：5

共 22 条

[1]

[Anonymous], 2019, IASLC 2019 WORLD C L

[2] THE RET PROTOONCOGENE IN SPORADIC PHEOCHROMOCYTOMAS - FREQUENT MEN 2-LIKE MUTATIONS AND NEW MOLECULAR DEFECTS [J].

BELDJORD, C ;

DESCLAUXARRAMOND, F ;

RAFFINSANSON, M ;

CORVOL, JC ;

DEKEYZER, Y ;

LUTON, JP ;

PLOUIN, PF ;

BERTAGNA, X .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :2063-2068

[3]

Borcek P, 2010, BMJ CASE REP, V2010

[4]

Drilon A, 2018, NAT REV CLIN ONCOL, V15, P151, DOI [10.1038/nrclinonc.2017.175, 10.1038/nrclinonc.2017.188]

[5] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].

Eisenhauer, E. A. ;

Therasse, P. ;

Bogaerts, J. ;

Schwartz, L. H. ;

Sargent, D. ;

Ford, R. ;

Dancey, J. ;

Arbuck, S. ;

Gwyther, S. ;

Mooney, M. ;

Rubinstein, L. ;

Shankar, L. ;

Dodd, L. ;

Kaplan, R. ;

Lacombe, D. ;

Verweij, J. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247

[6] Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer:: A 10-year follow-up study [J].

Elisei, Rossella ;

Cosci, Barbara ;

Romei, Cristina ;

Bottici, Valeria ;

Renzini, Giulia ;

Molinaro, Eleonora ;

Agate, Laura ;

Vivaldi, Agnese ;

Faviana, Pinuccia ;

Basolo, Fulvio ;

Miccoli, Paolo ;

Berti, Piero ;

Pacini, Furio ;

Pinchera, Aldo .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (03) :682-687

[7] Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma [J].

Grubbs, Elizabeth G. ;

Williams, Michelle D. ;

Scheet, Paul ;

Vattathil, Selina ;

Perrier, Nancy D. ;

Lee, Jeffrey E. ;

Gagel, Robert F. ;

Hai, Tao ;

Feng, Lei ;

Cabanillas, Maria E. ;

Cote, Gilbert J. .

THYROID, 2016, 26 (11) :1553-1562

[8] Response to Selective ET Inhibition With LOXO-292 in a Patient With RET Fusion-Positive Lung Cancer With Leptomeningeal Metastases [J].

Guo, Robin ;

Schreyer, Mark ;

Chang, Jason C. ;

Rothenberg, S. Michael ;

Henry, Dahlia ;

Cotzia, Paolo ;

Kris, Mark G. ;

Rekhtman, Natasha ;

Young, Robert J. ;

Hyman, David M. ;

Drilon, Alexander .

JCO PRECISION ONCOLOGY, 2019, 3 :1-6

[9] A MUTATION IN THE RET PROTOONCOGENE ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE-2B AND SPORADIC MEDULLARY-THYROID CARCINOMA [J].

HOFSTRA, RMW ;

LANDSVATER, RM ;

CECCHERINI, I ;

STULP, RP ;

STELWAGEN, T ;

LUO, Y ;

PASINI, B ;

HOPPENER, JWM ;

VANAMSTEL, HKP ;

ROMEO, G ;

LIPS, CJM ;

BUYS, CHCM .

NATURE, 1994, 367 (6461) :375-376

[10] RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients [J].

Kato, Shumei ;

Subbiah, Vivek ;

Marchlik, Erica ;

Elkin, Sheryl K. ;

Carter, Jennifer L. ;

Kurzrock, Razelle .

CLINICAL CANCER RESEARCH, 2017, 23 (08) :1988-1997

← 1 2 3 →